Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy.

Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy.

書誌詳細
主要な著者:	Heidt, S, Shankar, S, Muthusamy, A, San Segundo, D, Wood, K
フォーマット:	Journal article
言語:	English
出版事項:	2011

類似資料

Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection
著者:: H Senturk Ciftci, 等
出版事項: (2019-05-01)

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
著者:: Svensson Per-Arne, 等
出版事項: (2006-06-01)

The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
著者:: Chen Xu, 等
出版事項: (2023-01-01)

The impact of Th17 cells on transplant rejection and the induction of tolerance.
著者:: Heidt, S, 等
出版事項: (2010)

Clinical significance of serum CXCL9, CXCL10, and CXCL11 in patients with lupus nephritis
著者:: Shuo Wang, 等
出版事項: (2024-08-01)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
著者:: Xin Yu, 等
出版事項: (2022-11-01)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
著者:: Hamid Najmaddini, 等
出版事項: (2014-03-01)

Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementation
著者:: Claire Tinel, 等
出版事項: (2024-09-01)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
著者:: Peter S Fenwick, 等
出版事項: (2015-01-01)

High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization
著者:: Juliana Araújo de Carvalho Schettini, 等
出版事項: (2017-07-01)

An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation
著者:: Lisa K. Seiler, 等
出版事項: (2022-01-01)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
著者:: Xiaowan Yin, 等
出版事項: (2019-12-01)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
著者:: Alireza Nazari, 等
出版事項: (2020-03-01)

Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
著者:: Aseel F Khalaf, 等
出版事項: (2020-03-01)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
著者:: Monika Zajkowska, 等
出版事項: (2023-10-01)

Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation.
著者:: Heidt, S, 等
出版事項: (2011)

Pretransplant characteristics of kidney transplant recipients that predict posttransplant outcome
著者:: Martin Tepel, 等
出版事項: (2022-07-01)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
著者:: Tae Hyun Ban, 等
出版事項: (2019-12-01)

Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts
著者:: Cristina Antinozzi, 等
出版事項: (2021-05-01)

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
著者:: Victoria Callahan, 等
出版事項: (2021-06-01)

Elevated Plasma CXCL8 Concentrations in Significant Fibrosis but Not in Subclinical Rejection After Adult Liver Transplantation
著者:: Alejandro Campos-Murguia, MD, 等
出版事項: (2024-03-01)

Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.
著者:: Luciana Gabriel Nogueira, 等
出版事項: (2012-01-01)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
著者:: Ari Matsumoto, 等
出版事項: (2023-04-01)

Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance?
著者:: Chadha, R, 等
出版事項: (2011)

Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis
著者:: Pavithra Sampath, 等
出版事項: (2023-05-01)

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
著者:: Ilias Masouris, 等
出版事項: (2021-03-01)

Pertinent issues in pretransplant recipient workup
著者:: Pranjal Modi
出版事項: (2007-01-01)

Examination of serum miRNA levels in kidney transplant recipients with acute rejection.
著者:: Betts, G, 等
出版事項: (2014)

Examination of serum miRNA levels in kidney transplant recipients with acute rejection
著者:: Betts, G, 等
出版事項: (2014)

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE
著者:: Maximilian N. Kinzler, 等
出版事項: (2023-03-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
著者:: Christian Koch, 等
出版事項: (2022-12-01)

CXCR7 functions as a scavenger for CXCL12 and CXCL11.
著者:: Ulrike Naumann, 等
出版事項: (2010-02-01)

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
著者:: Hara Takahiko, 等
出版事項: (2014-05-01)

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
著者:: Riley M. Larkin, 等
出版事項: (2024-05-01)

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
著者:: Riley M. Larkin, 等
出版事項: (2024-09-01)

Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
著者:: Bin Huang, 等
出版事項: (2016-12-01)

Serum CXCL 9 as a Potential Biomarker for Patients with Ulcerative Colitis
著者:: Mohammed A. Qusay, 等
出版事項: (2024-07-01)

CXCL9/CXCL10 as biomarkers the monitoring of treatment responses in Pulmonary TB patients: a systematic review and meta-analysis
著者:: Zeyou Wei, 等
出版事項: (2024-09-01)

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
著者:: Jan-Hendrik Riedel, 等
出版事項: (2023-01-01)

CXCL9 and CXCL10 display an age-dependent profile in Chagas patients: a cohort study of aging in Bambui, Brazil
著者:: Fernanda Fortes de Araújo, 等
出版事項: (2020-05-01)